Lucido Louis C.'s Form 4 filing
BioCorRx Inc. (BICX) · filed Oct 11, 2022
- Accession no.
- 0001477932-22-007543
- Filed
- Oct 11, 2022
- Trade date
- Sep 6-Oct 6, 2022
- Filing delay
- 35 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions. Open-market purchases total $3.13K. It was filed 35 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lucido Louis C.CIK 0001539788 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 6, 2022 | Common Stock, par value $0.001 | PPurchaseAcquired | +10 | $2.10 | +$21 | 82,845 | Direct | |
| Oct 5, 2022 | Common Stock, par value $0.001 | PPurchaseAcquired | +1,000 | $2.02 | +$2,020 | 83,845 | Direct | |
| Oct 6, 2022 | Common Stock, par value $0.001 | PPurchaseAcquired | +360 | $1.90 | +$684 | 84,205 | Direct | |
| Oct 6, 2022 | Common Stock, par value $0.001 | PPurchaseAcquired | +120 | $1.90 | +$228 | 84,325 | Direct | |
| Oct 6, 2022 | Common Stock, par value $0.001 | PPurchaseAcquired | +100 | $1.73 | +$173 | 84,425 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.